Guardian Pharmacy Services, Inc.
GRDN
$26.03
-$0.20-0.76%
NYSE
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 4.56% | -2.74% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.56% | -2.74% | |||
| Cost of Revenue | 4.24% | -2.40% | |||
| Gross Profit | 5.90% | -4.11% | |||
| SG&A Expenses | 3.96% | 11.20% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.19% | -0.43% | |||
| Operating Income | 13.36% | -37.25% | |||
| Income Before Tax | -3.96% | -19.20% | |||
| Income Tax Expenses | -1.90% | -12.49% | |||
| Earnings from Continuing Operations | -4.81% | -21.69% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 16.00% | 71.57% | |||
| Net Income | -4.42% | -20.89% | |||
| EBIT | 13.36% | -37.25% | |||
| EBITDA | 10.77% | -29.53% | |||
| EPS Basic | -4.46% | -20.88% | |||
| Normalized Basic EPS | 12.63% | -34.32% | |||
| EPS Diluted | -4.86% | -21.97% | |||
| Normalized Diluted EPS | 12.14% | -34.51% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.46% | 0.30% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||